Diabetic Nephropathies
Showing 1 - 25 of 6,318
Diabetic Nephropathies Trial (soy protein drink, casein protein drink)
Completed
- Diabetic Nephropathies
- soy protein drink
- casein protein drink
- (no location specified)
Apr 21, 2023
Finerenone in Heart Failure With Reduced Ejection Fraction
Not yet recruiting
- Heart Failure With Reduced Ejection Fraction
- +2 more
- (no location specified)
Jul 26, 2023
Hyperspectral Imaging in the Diagnosis of Glomerular Diseases
Not yet recruiting
- Glomerulonephritis, IGA
- +4 more
- Microscopic hyperspectral imaging system
- (no location specified)
Mar 31, 2023
Diabetic Nephropathies Trial in Tanta (Niclosamide, Placebo oral tablet)
Completed
- Diabetic Nephropathies
- Niclosamide
- Placebo oral tablet
-
Tanta, EgyptFaculty of Pharmacy, Tanta University
Oct 19, 2022
Prevent Diabetic Kidney Disease Among Egyptians
Not yet recruiting
- Diabetes Mellitus Without Complication
- (no location specified)
Oct 6, 2023
Diabetic Kidney Disease Trial (Soleus ms exercise)
Not yet recruiting
- Diabetic Kidney Disease
- Soleus ms exercise
- (no location specified)
Nov 4, 2023
Diagnostic Value of Serum Cathepsin S and Chromogranin A in DKD
Not yet recruiting
- Diabetic Kidney Disease
- cathepsin S and chromogranin A
- (no location specified)
Oct 5, 2023
Revealing Engagement Dynamics Among Diabetic Kidney Disease
Not yet recruiting
- Diabetic Kidney Disease
-
San Francisco, CaliforniaPower Life Sciences
Oct 20, 2023
Nephropathy, Diabetic Nephropathies, Diabetes, Type 1 Trial in Herlev (Sotagliflozin, Placebo)
Not yet recruiting
- Nephropathy
- +6 more
- Sotagliflozin
- Placebo
-
Herlev, DenmarkSteno Diabetes Center Copenhagen
Nov 19, 2023
Chronic Kidney Diseases, Diabetes, Diabetic Nephropathies Trial in Rochester (Fisetin, Placebo oral capsule)
Enrolling by invitation
- Chronic Kidney Diseases
- +2 more
- Fisetin
- Placebo oral capsule
-
Rochester, MinnesotaMayo Clinic in Rochester
Nov 9, 2022
Thickening of Bowman's Capsule on Clinical Prognosis of Diabetic
Not yet recruiting
- Diabetic Kidney Disease
- Extracellular Matrix Alteration
- no intervention
- (no location specified)
Sep 15, 2023
Diabetic Nephropathies Trial in Daegu (CU01-1001, Placebo)
Recruiting
- Diabetic Nephropathies
- CU01-1001
- Placebo
-
Daegu, Korea, Republic ofYeongnam University Medical Center
Feb 6, 2023
Diabetic Nephropathy Type 2 Trial (Acetylsalicylic Acid, Placebo)
Not yet recruiting
- Diabetic Nephropathy Type 2
- Acetylsalicylic Acid
- Placebo
- (no location specified)
Sep 28, 2023
Diabetic Nephropathies Trial in Mansoura (Valsartan 80 mg, Empagliflozin 10 MG, Levocetirizine)
Recruiting
- Diabetic Nephropathies
- Valsartan 80 mg
- +2 more
-
Mansoura, EgyptMansoura University
Nov 28, 2022
Urinary Exosome in Type 2 Diabetic Nephropathy and Evaluation of
Active, not recruiting
- Diabetic Nephropathy
- Grouping based on previous laboratory results, no intervention.
-
Jinan, Shandong, ChinaQianfoshan Hospital
Oct 24, 2023
CRP to Serum Albumin Ratio in Type 2 DM é Diabetic Nephropathy
Not yet recruiting
- Type 2 DM /Diabetic Nephropathy
- (no location specified)
Jan 28, 2023
Urinary Exosome in Type 2 Diabetic Kidney Disease and Evaluation
Active, not recruiting
- Diabetic Nephropathy
- Grouping based on previous laboratory results, no intervention.
-
Jinan, Shandong, ChinaQianfoshan Hospital
Nov 8, 2023
Chronic Kidney Disease Among Type 2 Diabetic Assiut University
Recruiting
- Type 2 Diabetes With Renal Manifestations
-
Assiut, EgyptAssiut
May 5, 2023
Diabetic Kidney Disease Trial in Herlev (ACEi / ARB, SGLT2i, finerenone, semaglutide, pentoxifylline, hydrochlorthiazide,
Recruiting
- Diabetic Kidney Disease
- ACEi / ARB, SGLT2i, finerenone, semaglutide, pentoxifylline, hydrochlorthiazide, baricitinib
-
Herlev, DenmarkDepartment of Nephrology, Herlev and Gentofte Hospital
May 31, 2023
High Incidence of Thrombotic Events in Patients With MN and DKD
Active, not recruiting
- Glomerulonephritis, Membranous
- +3 more
- Grouping based on previous laboratory results, no intervention.
-
Jinan, Shandong, ChinaQianfoshan Hospital
Dec 7, 2022
Type 1 Diabetic Nephropathy Trial in Cairo (oral sitagliptin supplementation)
Completed
- Type 1 Diabetic Nephropathy
- oral sitagliptin supplementation
-
Cairo, EgyptNancy Elbarbary
Nov 2, 2023
Diabetic Nephropathies Trial in Dalian (Huangqi Guizhi Wuwu decoction, Dapagliflozin)
Recruiting
- Diabetic Nephropathies
- Huangqi Guizhi Wuwu decoction
- Dapagliflozin
-
Dalian, Liaoning, ChinaThe First Affiliated Hospital of Dalian medical university
Jun 10, 2022
Kidney Diseases, Kidney Failure, Chronic, Diabetic Nephropathy Trial in New York
Recruiting
- Kidney Diseases
- +4 more
-
New York, New YorkThe Rogosin Institute
Feb 28, 2022
Proteinuria, Kidney Dysfunction, Blood Pressure Trial in Hanzhou (Azilsartan, Losartan)
Recruiting
- Proteinuria
- +3 more
-
Hanzhou, Zhejiang, Chinathe Second Afficiated Hospital, Zhejiang University, School of M
Feb 22, 2023